Your browser doesn't support javascript.
loading
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol.
Spierings, Julia; van Rhenen, Anna; Welsing, Paco Mw; Marijnissen, Anne Ca; De Langhe, Ellen; Del Papa, Nicoletta; Dierickx, Daan; Gheorghe, Karina R; Henes, Joerg; Hesselstrand, Roger; Kerre, Tessa; Ljungman, Per; van de Loosdrecht, Arjan A; Marijt, Erik Waf; Mayer, Miro; Schmalzing, Marc; Schroers, Roland; Smith, Vanessa; Voll, Reinhard E; Vonk, Madelon C; Voskuyl, Alexandre E; de Vries-Bouwstra, Jeska K; Walker, Ulrich A; Wuttge, Dirk M; van Laar, Jacob M.
Afiliação
  • Spierings J; Department of Rheumatology & Clinical Immunology, UMC Utrecht, Utrecht, The Netherlands J.Spierings@umcutrecht.nl.
  • van Rhenen A; Department of Haematology, UMC Utrecht, Utrecht, the Netherlands.
  • Welsing PM; Department of Rheumatology & Clinical Immunology, UMC Utrecht, Utrecht, The Netherlands.
  • Marijnissen AC; Department of Rheumatology & Clinical Immunology, UMC Utrecht, Utrecht, The Netherlands.
  • De Langhe E; Department of Rheumatology, KU Leuven Hospital, Leuven, Flanders, Belgium.
  • Del Papa N; Department of Rheumatology, ASST Gaetano Pini, Milano, Lombardia, Italy.
  • Dierickx D; Department of Haematology, KU Leuven Hospital, Leuven, Flanders, Belgium.
  • Gheorghe KR; Department of Rheumatology, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Henes J; Department for Internal Medicine (Oncology, Haematology, Rheumatology and Immunology), University Hospital Tubingen, Tubingen, Baden-Württemberg, Germany.
  • Hesselstrand R; Department of Clinical Sciences, Lund, Section for Rheumatology, Lund University and Skåne University Hospital, Lund, Skåne, Sweden.
  • Kerre T; Department of Haematology, University Hospital Ghent, Gent, Oost-Vlaanderen, Belgium.
  • Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • van de Loosdrecht AA; Department of Haematology, Amsterdam UMC Locatie VUmc, Amsterdam, Noord-Holland, The Netherlands.
  • Marijt EW; Department of Haematology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.
  • Mayer M; Department of Clinical Immunology and Rheumatology, University Hospital Centre Zagreb, Zagreb, Croatia.
  • Schmalzing M; Department of Internal Medicine, Rheumatology and Clinical Immunology, University Hospital Wurzburg, Wurzburg, Bayern, Germany.
  • Schroers R; Department of Medicine, Haematology and Oncology, Ruhr University of Bochum, Faculty of Medicine, Bochum, Nordrhein-Westfalen, Germany.
  • Smith V; Department of Rheumatology, University Hospital Ghent, Gent, Oost-Vlaanderen, Belgium.
  • Voll RE; Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center (IRC), Gent, Oost-Vlaanderen, Belgium.
  • Vonk MC; Department of Rheumatology, Medical Center-University of Freiburg, Freiburg, Baden-Württemberg, Germany.
  • Voskuyl AE; Rheumatology, Radboudumc, Nijmegen, Gelderland, The Netherlands.
  • de Vries-Bouwstra JK; Department of Rheumatology, Amsterdam UMC Locatie VUmc, Amsterdam, Noord-Holland, The Netherlands.
  • Walker UA; Rheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.
  • Wuttge DM; Department of Rheumatology, University Hospital Basel, Basel, Switzerland.
  • van Laar JM; Department of Clinical Sciences, Lund, Section for Rheumatology, Lund University and Skåne University Hospital, Lund, Skåne, Sweden.
BMJ Open ; 11(3): e044483, 2021 03 18.
Article em En | MEDLINE | ID: mdl-33737437

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Esclerodermia Difusa Tipo de estudo: Clinical_trials / Guideline Aspecto: Ethics / Patient_preference Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Esclerodermia Difusa Tipo de estudo: Clinical_trials / Guideline Aspecto: Ethics / Patient_preference Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda País de publicação: Reino Unido